BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 4394123)

  • 1. [Effect of a new beta-receptor blocking substance on human hemodynamics and metabolism].
    Niessner H; Lujf A; Moser K
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):277-81. PubMed ID: 4394123
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental studies of the modification of myocardial metabolism with oxyfedrin].
    Niessner H; Lujf A; Moser K
    Z Gesamte Exp Med Einschl Exp Chir; 1969; 151(2):163-74. PubMed ID: 5357616
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of oxyfedrin on hemodynamics and myocardial and hepatic metabolism in intact dogs after beta-adrenergic blockade].
    Niessner H; Raberger G; Lujf A; Moser K
    Res Exp Med (Berl); 1972; 158(4):288-97. PubMed ID: 5085437
    [No Abstract]   [Full Text] [Related]  

  • 4. Circulatory effects of oxprenolol, a new beta-adrenergic blocking agent.
    Reale A; Motolese M; Imhof P
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):288-93. PubMed ID: 4394124
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of ajmaline on ECG, hemodynamics and metabolism in man].
    Benda L; Lujf A; Moser K
    Wien Z Inn Med; 1966 Oct; 47(10):421-6. PubMed ID: 6005176
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of intravenously administered cortisol--with and without the addition of insulin or pretreatment with propranolol--on various parameters of fat and carbohydrate metabolism in blood plasma of human beings.
    Mischke WJ; Ebers S; Boisch KH; Tamm J
    Acta Endocrinol Suppl (Copenh); 1974; 186():1-45. PubMed ID: 4522424
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of prostaglandin E1 upon the general and coronary haemodynamics and metabolism of the intact dog.
    Maxwell GM
    Br J Pharmacol Chemother; 1967 Sep; 31(1):162-8. PubMed ID: 6055250
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipid and carbohydrate metabolites in the blood of normal and obese subjects following intravenous administration of insulin, with special attention to the counterregulatory phases].
    Schmidt H; von Rotteck G; Voigt KD
    Endokrinologie; 1970; 57(1):1-9. PubMed ID: 4923989
    [No Abstract]   [Full Text] [Related]  

  • 9. [Central hemodynamics of the hyperkinetic syndrome under blockade with beta receptors].
    Juchems R; Wertz U
    Munch Med Wochenschr; 1969 Dec; 111(49):2567-71. PubMed ID: 4392881
    [No Abstract]   [Full Text] [Related]  

  • 10. General and coronary haemodynamic effects of 1-(O-allyloxphenoxy)-3-isopropylamino-2-propanol hydrochloride.
    Maxwell GM
    Arch Int Pharmacodyn Ther; 1968 May; 173(1):226-31. PubMed ID: 5657822
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemodynamic action of talinolol (Cordanum, 02-115), a new beta-receptor blocking substance, in man].
    Wolf P; Feller K; Femmer K
    Pharmazie; 1975 Oct; 30(10):678-81. PubMed ID: 696
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacologic effect of a beta-receptor blocking agent (LB-46) on hemodynamics].
    Köhler M
    Z Kreislaufforsch; 1970 Aug; 59(8):708-19. PubMed ID: 5513291
    [No Abstract]   [Full Text] [Related]  

  • 13. Some haemodynamic effects of LB 46 (Visken).
    Smyth AJ; Watson O; Peel JS; Turner AS
    N Z Med J; 1970 Oct; 72(461):246-7. PubMed ID: 4395124
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in regional hemodynamics in response to blocking of the adrenergic beta receptors].
    Granata L; Caraffa Braga E; Cevese A; Data PG
    Boll Soc Ital Biol Sper; 1970 Feb; 46(4):170-3. PubMed ID: 4396928
    [No Abstract]   [Full Text] [Related]  

  • 15. On the clinical pharmacology of talinolol, a new beta 1-adrenoceptor blocking agent.
    Haustein KO; Fiehring H; Oltmanns G; Femmer K
    Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):465-70. PubMed ID: 43294
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular, metabolic, and hormonal responses to noradrenaline in diabetic patients with autonomic neuropathy.
    Dejgaard A; Andersen P; Hvidberg A; Hilsted J
    Diabet Med; 1996 Nov; 13(11):983-9. PubMed ID: 8946158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical contribution to the knowledge of the relations between cyclic 3',5' AMP and catecholamines in cardiovascular function. (Study with adrenergic antagonists)].
    Starcich R; Barbaresi F; Volta G; Manfredi M
    Minerva Cardioangiol; 1967 Dec; 15(12):844-53. PubMed ID: 5610486
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of immediate haemodynamic effects of three beta-adrenergic blocking agents.
    Rivier JL; Nissiotis E; Jaeger M
    Postgrad Med J; 1970 Nov; ():Suppl:44-9. PubMed ID: 4395457
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of the combined effect of alpha-blocking and beta-blocking drugs on tolerance to exertion in patients with acute coronary insufficiency].
    Pavarani A; Volta G; Barbaresi F; Starcich R
    Folia Cardiol; 1969; 28(1):37-41. PubMed ID: 4391632
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological aspects of oxprenolol.
    Brunner H; Hedwall PR; Maier R; Meier M
    Postgrad Med J; 1970 Nov; ():Suppl:5-14. PubMed ID: 4395460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.